<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The following on progression to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and markers of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> includes commentariess on the expression of claudin 4 in Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>; the role of acid and <z:chebi fb="0" ids="22868">bile salts</z:chebi>; the role of insulin-like growth factor; the value of reactive oxygen species; the importance of abnormal methylation; genetic alterations in stromal cells and genomic changes in the epithelial cells; the value of confocal laser endomicroscopy for the subsurface analysis of the mucosa; indications for <z:chebi fb="0" ids="35664">statins</z:chebi> as adjuvant chemotherapeutic agent; the sequence of molecular events in malignant progression in Barrett's mucosa; and the value of the macroscopic markers and of p53 mutations </plain></SENT>
</text></document>